Latest in Cardiology: Interventional

Reuters Health • The Doctor's Channel Daily Newscast

More evidence for intracoronary over intravenous GPI in primary PCI

NEW YORK (Reuters Health) – Three cardiologists from China say intracoronary administration of a glycoprotein IIb/IIIa receptor inhibitor (GPI) “can be recommended as a preferred regimen” during primary percutaneous coronary intervention (pPCI) in patients with ST-segment elevation myocardial...
NEW YORK (Reuters Health) – Discontinuation of aspirin within 5 days of combined coronary artery bypass graft (CABG) and valve surgery is associated with an increased risk of postoperative bleeding, compared with earlier discontinuation. “Physicians should weigh the risk of bleeding vs. the benefit for...

Reuters Health • The Doctor's Channel Daily Newscast

Sirolimus-eluting stent a good option for BMS and DES in-stent restenosis

NEW YORK (Reuters Health) – Percutaneous placement of a sirolimus-eluting stent (SES) is a safe and effective way to address either bare-metal (BMS) or drug-eluting (DES) in-stent restenosis, according to a report this month in JACC: Cardiovascular Interventions from an international team of interventional...